SIRT7 appears to promote proliferation and survival of pancreatic ductal adenocarcinoma (PDA) by epigenetically repressing expression of tumor suppressors through H3K18 deacetylation (Fig. 3A and Table 1) [38]. Here, SIRT7 is linked to neoplasm.